WOONSOCKET, R.I., June 30, 2025 — CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Thursday, July 31st, 2025, at 8:00 a.m. ET to discuss second quarter 2025 financial ...

Our formulary strategy is centered around providing cost-effective, clinically appropriate prescription coverage We remove barriers to care, increase access to new treatments and make them more ...

GLP-1s are revolutionary drugs in the treatment of obesity, but they're very expensive, and this creates a real barrier to people who need access to these drugs.